Healthcare
Provepharm UK
Watford, England
Company profile
About the company
Provepharm UK is the British subsidiary of a pharmaceutical group that develops, manufactures and supplies hospital medicines and active pharmaceutical ingredients. The UK team supports healthcare customers and commercial activity from Watford, while the parent business handles product development, production and international distribution. Its portfolio focuses on established molecules used in clinical and hospital settings.
Public claim
What the listing records.
“Provepharm UK commits to net zero by 2050 and adopts its parent group's target to reduce Scope 1, Scope 2 and Scope 3 emissions by 7% annually from 2024 to 2033.”
Evidence note
The director-signed March 2026 plan uses a consultancy-prepared group baseline of 69,548 tCO2e and projects a 40% reduction by 2031.
Source type: Public report